XFOR
X4 Pharmaceuticals, Inc
-0.09 (-2.71%)3.42USD201K成交股數339M市值2.7本益比(近四季)21.4股價營收比+346.3%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 356K · 3 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 429K |
| 近 180 天 淨額 | −429K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | 08-13 | Craig Adam R | Executive Chairman | S 公開市場賣出 | 47.4K | 4.44 | 211K | 329K | SEC |
| 2026-08-12 | 08-13 | Volpone John | President | S 公開市場賣出 | 24.6K | 4.44 | 109K | 265K | SEC |
| 2026-06-30 | 07-01 | KIRSKE DAVID | Chief Financial Officer | S 公開市場賣出 | 8.5K | 4.26 | 36K | 168K | SEC |
| 2026-05-12 | 05-13 | KIRSKE DAVID | Chief Financial Officer | S 公開市場賣出 | 17.0K | 4.29 | 73K | 176K | SEC |
| 2025-10-23 | 10-27 | Craig Adam R | Executive Chairman | P 公開市場買進 | 86.2K | 2.90 | 250K | 376K | SEC |
| 2025-08-14 | 08-14 | Craig Adam R | Executive Chairman | A 獲配股票 | 290K | – | – | 290K | SEC |
| 2025-08-14 | 08-14 | KIRSKE DAVID | Chief Financial Officer | A 獲配股票 | 193K | – | – | 193K | SEC |
| 2025-08-14 | 08-14 | Volpone John | President | A 獲配股票 | 290K | – | – | 290K | SEC |
| 2025-06-09 | 06-10 | Bridger Gary | Director | A 獲配股票 | 1.5K | – | – | 4.7K | SEC |
| 2025-06-09 | 06-10 | de Craecker Francoise | Director | A 獲配股票 | 1.5K | – | – | 4.7K | SEC |
| 2025-06-09 | 06-10 | MCGIRR DAVID W J | Director | A 獲配股票 | 1.5K | – | – | 4.7K | SEC |
| 2025-06-09 | 06-10 | Woods Keith | Director | A 獲配股票 | 1.5K | – | – | 6.0K | SEC |
| 2025-06-09 | 06-10 | Stewart Murray | Director | A 獲配股票 | 1.5K | – | – | 7.9K | SEC |
| 2025-06-09 | 06-10 | WYZGA MICHAEL S | Director | A 獲配股票 | 1.5K | – | – | 5.6K | SEC |
| 2025-05-20 | 07-03 | Thoren Natasha Fay | Chief Legal Officer | A 獲配股票 | 3.3K | – | – | 9.5K | SEC |
| 2025-05-16 | 06-03 | Baldry Mark | Chief Commercial Officer | A 獲配股票 | 1.0K | 2.48 | 3K | 25.3K | SEC |
| 2025-05-16 | 05-20 | Baldry Mark | Chief Commercial Officer | P 公開市場買進 | 1.0K | 2.48 | 3K | 25.3K | SEC |
| 2025-02-12 | 02-14 | Arbet-Engels Christophe | Chief Medical Officer | A 獲配股票 | 850K | – | – | 864K | SEC |
| 2025-02-12 | 02-14 | Ragan Paula | President and CEO | A 獲配股票 | 2.3M | – | – | 3.3M | SEC |
| 2025-02-12 | 02-14 | Mostafa Adam S. | Chief Financial Officer | A 獲配股票 | 850K | – | – | 850K | SEC |
| 2025-02-12 | 02-14 | DiBiase Mary | Chief Operating Officer | A 獲配股票 | 650K | – | – | 1.1M | SEC |
| 2025-02-12 | 02-14 | Baldry Mark | Chief Commercial Officer | A 獲配股票 | 600K | – | – | 729K | SEC |
| 2025-01-24 | 01-27 | Baldry Mark | Chief Commercial Officer | S 公開市場賣出 | 29.2K | 0.45 | 13K | 94.1K | SEC |
| 2025-01-24 | 01-27 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出 | 22.3K | 0.45 | 10K | 491K | SEC |
| 2025-01-24 | 01-27 | Arbet-Engels Christophe | Chief Medical Officer | S 公開市場賣出 | 11.6K | 0.45 | 5K | 14.2K | SEC |
| 2025-01-24 | 01-27 | Mostafa Adam S. | Chief Financial Officer | S 公開市場賣出 | 74.8K | 0.45 | 34K | 0 | SEC |
| 2025-01-24 | 01-27 | Ragan Paula | President and CEO | S 公開市場賣出 | 76.5K | 0.45 | 34K | 1.1M | SEC |
| 2025-01-23 | 01-27 | Mostafa Adam S. | Chief Financial Officer | A 獲配股票 | 74.8K | – | – | 74.8K | SEC |
| 2025-01-23 | 01-27 | Baldry Mark | Chief Commercial Officer | A 獲配股票 | 74.8K | – | – | 123K | SEC |
| 2025-01-23 | 01-27 | Arbet-Engels Christophe | Chief Medical Officer | A 獲配股票 | 25.8K | – | – | 25.8K | SEC |
| 2025-01-23 | 01-27 | DiBiase Mary | Chief Operating Officer | A 獲配股票 | 61.2K | – | – | 513K | SEC |
| 2025-01-23 | 01-27 | Ragan Paula | President and CEO | A 獲配股票 | 170K | – | – | 1.2M | SEC |
| 2024-11-15 | 02-14 | Baldry Mark | Chief Commercial Officer | P 公開市場買進 | 13.4K | 0.34 | 5K | 129K | SEC |
| 2024-11-15 | 11-19 | Ragan Paula | President and CEO | S 公開市場賣出 | 31.9K | 0.39 | 12K | 994K | SEC |
| 2024-10-15 | 10-16 | Ragan Paula | President and CEO | S 公開市場賣出 | 31.9K | 0.56 | 18K | 1.0M | SEC |
| 2024-10-07 | 10-08 | Baldry Mark | Chief Commercial Officer | S 公開市場賣出 | 11.1K | 0.58 | 6K | 48.5K | SEC |
| 2024-10-07 | 10-08 | Ragan Paula | President and CEO | S 公開市場賣出 | 239K | 0.55 | 132K | 1.1M | SEC |
| 2024-10-07 | 10-08 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出 | 67.7K | 0.57 | 39K | 452K | SEC |
| 2024-10-07 | 10-08 | Taveras Arthur | Chief Scientific Officer | S 公開市場賣出 | 76.9K | 0.56 | 43K | 388K | SEC |
| 2024-10-07 | 10-08 | Mostafa Adam S. | Chief Financial Officer | S 公開市場賣出 | 231K | 0.55 | 127K | 0 | SEC |
| 2024-10-04 | 10-08 | Mostafa Adam S. | Chief Financial Officer | A 獲配股票 | 231K | – | – | 231K | SEC |
| 2024-10-04 | 10-08 | Ragan Paula | President and CEO | A 獲配股票 | 532K | – | – | 1.3M | SEC |
| 2024-10-04 | 10-08 | Baldry Mark | Chief Commercial Officer | A 獲配股票 | 34.9K | – | – | 59.6K | SEC |
| 2024-10-04 | 10-08 | Taveras Arthur | Chief Scientific Officer | A 獲配股票 | 231K | – | – | 465K | SEC |
| 2024-10-04 | 10-08 | DiBiase Mary | Chief Operating Officer | A 獲配股票 | 231K | – | – | 520K | SEC |
| 2024-09-09 | 09-11 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出 | 2.6K | 0.66 | 2K | 289K | SEC |
| 2024-06-10 | 06-11 | WYZGA MICHAEL S | Director | A 獲配股票 | 45.0K | – | – | 122K | SEC |
| 2024-06-10 | 06-11 | Aliski William | Director | A 獲配股票 | 45.0K | – | – | 96.7K | SEC |
| 2024-06-10 | 06-11 | MCGIRR DAVID W J | Director | A 獲配股票 | 45.0K | – | – | 96.7K | SEC |
| 2024-06-10 | 06-11 | Stewart Murray | Director | A 獲配股票 | 45.0K | – | – | 192K | SEC |
| 2024-06-10 | 06-11 | Bridger Gary | Director | A 獲配股票 | 45.0K | – | – | 96.7K | SEC |
| 2024-06-10 | 06-11 | Woods Keith | Director | A 獲配股票 | 45.0K | – | – | 135K | SEC |
| 2024-06-10 | 06-11 | Lawton Alison Frances | Director | A 獲配股票 | 45.0K | – | – | 96.7K | SEC |
| 2024-06-10 | 06-11 | de Craecker Francoise | Director | A 獲配股票 | 45.0K | – | – | 96.7K | SEC |
| 2024-05-17 | 02-14 | Baldry Mark | Chief Commercial Officer | P 公開市場買進 | 21.6K | 0.68 | 15K | 116K | SEC |
| 2024-03-11 | 03-11 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出 | 15.4K | 0.88 | 14K | 292K | SEC |
| 2024-03-11 | 03-11 | Ragan Paula | President and CEO | S 公開市場賣出 | 49.7K | 0.88 | 44K | 765K | SEC |
| 2024-03-11 | 03-11 | Mostafa Adam S. | Chief Financial Officer | S 公開市場賣出 | 52.5K | 0.88 | 46K | 0 | SEC |
| 2024-03-11 | 03-11 | Taveras Arthur | Chief Scientific Officer | S 公開市場賣出 | 14.2K | 0.88 | 13K | 234K | SEC |
| 2024-02-12 | 02-12 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出 | 3.7K | 1.01 | 4K | 307K | SEC |
| 2024-02-12 | 02-12 | Taveras Arthur | Chief Scientific Officer | S 公開市場賣出 | 787 | 1.01 | 794.87 | 249K | SEC |
| 2024-02-12 | 02-12 | Ragan Paula | President and CEO | S 公開市場賣出 | 21.7K | 1.01 | 22K | 815K | SEC |
| 2024-02-12 | 02-12 | Mostafa Adam S. | Chief Financial Officer | S 公開市場賣出 | 27.7K | 1.01 | 28K | 52.5K | SEC |
| 2023-11-03 | 11-03 | Ragan Paula | President and CEO | S 公開市場賣出(10b5-1) | 39.9K | 0.90 | 36K | 836K | SEC |
| 2023-11-01 | 11-03 | Taveras Arthur | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 67.7K | 0.73 | 49K | 249K | SEC |
| 2023-11-01 | 11-03 | Ragan Paula | President and CEO | S 公開市場賣出(10b5-1) | 200K | 0.73 | 146K | 876K | SEC |
| 2023-11-01 | 11-03 | Mostafa Adam S. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 231K | 0.73 | 168K | 80.2K | SEC |
| 2023-11-01 | 11-03 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出(10b5-1) | 67.7K | 0.73 | 49K | 311K | SEC |
| 2023-11-01 | 11-03 | Baldry Mark | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 10.3K | 0.73 | 7K | 24.7K | SEC |
| 2023-10-31 | 11-02 | DiBiase Mary | Chief Operating Officer | A 獲配股票 | 231K | – | – | 379K | SEC |
| 2023-10-31 | 11-02 | Taveras Arthur | Chief Scientific Officer | A 獲配股票 | 231K | – | – | 317K | SEC |
| 2023-10-31 | 11-02 | Ragan Paula | President and CEO | A 獲配股票 | 532K | – | – | 1.1M | SEC |
| 2023-10-31 | 11-02 | Mostafa Adam S. | Chief Financial Officer | A 獲配股票 | 231K | – | – | 311K | SEC |
| 2023-10-31 | 11-02 | Baldry Mark | Chief Commercial Officer | A 獲配股票 | 34.9K | – | – | 34.9K | SEC |
| 2023-10-16 | 10-18 | Woods Keith | Director | A 獲配股票 | 90.0K | – | – | 90.0K | SEC |
| 2023-09-08 | 09-12 | DiBiase Mary | Chief Operating Officer | S 公開市場賣出 | 2.6K | 1.25 | 3K | 148K | SEC |
| 2023-08-18 | 08-22 | WYZGA MICHAEL S | Director | P 公開市場買進 | 25.0K | 1.20 | 30K | 76.7K | SEC |
| 2023-08-10 | 08-11 | Stewart Murray | Interim Chief Medical Officer | S 公開市場賣出 | 130K | 1.06 | 138K | 147K | SEC |
| 2023-08-09 | 08-11 | Stewart Murray | Interim Chief Medical Officer | A 獲配股票 | 270K | – | – | 277K | SEC |
| 2023-06-30 | 07-05 | Mostafa Adam S. | Chief Financial Officer | S 公開市場賣出 | 2.6K | 1.89 | 5K | 80.2K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MORGAN STANLEY | 9.5M | 44.2M | 新進 | 新進 |
| FMR LLC | 8.3M | 38.9M | 新進 | 新進 |
| Bain Capital Life Sciences Investors, LLC | 8.0M | 37.2M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 7.9M | 37.0M | 新進 | 新進 |
| Kalehua Capital Management LLC | 7.4M | 34.8M | 新進 | 新進 |
| Saturn V Capital Management LP | 7.0M | 32.6M | 新進 | 新進 |
| Empery Asset Management, LP | 6.9M | 32.4M | 新進 | 新進 |
| Deep Track Capital, LP | 5.9M | 27.5M | 新進 | 新進 |
| BlackRock, Inc. | 5.6M | 25.9M | 新進 | 新進 |
| Nantahala Capital Management, LLC | 4.9M | 22.9M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | 17.4M | 新進 | 新進 |
| Rosalind Advisors, Inc. | 3.2M | 15.0M | 新進 | 新進 |
| BRAIDWELL LP | 2.9M | 13.6M | 新進 | 新進 |
| Blackstone Inc. | 2.7M | 12.5M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 2.6M | 12.0M | 新進 | 新進 |
| BVF INC/IL | 2.2M | 10.4M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | 9.8M | 新進 | 新進 |
| Venrock Adviser, LLC | 1.9M | 9.0M | 新進 | 新進 |
| SAMSARA BIOCAPITAL, LLC | 1.4M | 6.5M | 新進 | 新進 |
| STATE STREET CORP | 1.3M | 6.1M | 新進 | 新進 |
| Woodline Partners LP | 1.0M | 4.7M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 917K | 4.3M | 新進 | 新進 |
| NORTHERN TRUST CORP | 653K | 3.0M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 572K | 2.7M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 542K | 2.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 88 +6 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 88 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 102M · 100.0% |
| 合計季末市值 | 476M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.2M |
|---|---|
| 與上期比 | +0.3% |
| 佔流通股數 | 7.25% |
| 日均成交量 | 560K |
| 回補天數 | 12.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.2M | +0.3% | 7.25% | 560K | 12.8 |
| 2026-08-14 | 7.2M | -1.9% | 7.23% | 804K | 8.9 |
| 2026-07-31 | 7.3M | +12.3% | 7.36% | 573K | 12.8 |
| 2026-07-15 | 6.5M | +18.1% | 6.56% | 664K | 9.8 |
| 2026-06-30 | 5.5M | +31.7% | 5.55% | 1.6M | 3.5 |
| 2026-06-15 | 4.2M | +24.0% | 4.22% | 421K | 9.9 |
| 2026-05-29 | 3.4M | +15.3% | 3.40% | 363K | 9.3 |
| 2026-05-15 | 2.9M | -6.2% | 2.95% | 344K | 8.5 |
| 2026-04-30 | 3.1M | -0.9% | 3.14% | 373K | 8.4 |
| 2026-04-15 | 3.1M | +0.7% | 3.17% | 415K | 7.6 |
| 2026-03-31 | 3.1M | -10.7% | 3.15% | 436K | 7.2 |
| 2026-03-13 | 3.5M | +1.2% | 3.53% | 619K | 5.7 |
| 2026-02-27 | 3.5M | +2.3% | 3.49% | 562K | 6.2 |
| 2026-02-13 | 3.4M | +8.3% | 3.41% | 519K | 6.5 |
| 2026-01-30 | 3.1M | +0.9% | 3.15% | 248K | 12.6 |
| 2026-01-15 | 3.1M | +3.1% | 3.12% | 423K | 7.3 |
| 2025-12-31 | 3.0M | -4.9% | 3.03% | 1.0M | 2.9 |
| 2025-12-15 | 3.2M | +27.1% | 3.18% | 748K | 4.2 |
| 2025-11-28 | 2.5M | +27.8% | 2.50% | 488K | 5.1 |
| 2025-11-14 | 1.9M | +30.1% | 1.96% | 560K | 3.5 |
| 2025-10-31 | 1.5M | -16.4% | 1.51% | 2.4M | 1.0 |
| 2025-10-15 | 1.8M | -12.8% | 1.80% | 390K | 4.6 |
| 2025-09-30 | 2.0M | +8.2% | 2.07% | 433K | 4.7 |
| 2025-09-15 | 1.9M | +21.7% | 1.91% | 619K | 3.1 |
| 2025-08-29 | 1.6M | -37.0% | 1.57% | 2.5M | 1.0 |
| 2025-08-15 | 2.5M | +141.5% | 2.49% | 17.0M | 1.0 |